Update: 2021-11-01 13:25:28 UTC; added F@H history; elaborated on contest.--Bytrammartyb writes:Welcome to November! Here's a quick update on the site.Holiday
Snotnose writes:You'll never guess what the most back-ordered item in the Apple catalog is. Go on, guess. I promise you'll be wrong, because it's the inane thing you can think of.Apple's Most Back-Ordered New Product Is Not What You Expect:
canopic jug writes:Back in 1998, Paul Strassmann, a former CIO of Xerox, NASA, and the US Department of Defense, wrote in Computerworld about how Microsoft's overly complex, defective, and vulnerable systems which were already a threat to national security even back then. The intervening time has shown Strassmann to have been more than correct as the problems he identified with Microsoft and its products worsen monatonically. Mitchel Lewis writes a guest post at Techrights about the current situation and how Microsoft remains a security threat against national security and systematic reliability of our computer-based society today:
Intel Targeting Zettascale (1000 Exaflops) by 2027?takyon writes:'We will not rest until the periodic table is exhausted' says Intel CEO on quest to keep Moore's Law alive
looorg writes:Facebook is changing its name to Meta as it focuses on the virtual worldFacebook is now a meta product.I'm not certain which name is worse; meta or alphabetI doubt it will wash away the stink, people will still refer to it as Facebook just as everyone just appear to call all things google related to alphabet.https://www.washingtonpost.com/technology/2021/10/28/facebook-meta-name-change/
dalek writes:As expected, the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended to amend the emergency use authorization for Comirnaty, Pfizer's COVID-19 vaccine, for use by children of ages 5 to 11. The vote was 17-0 with one committee member abstaining. The committee was concerned about the possible side effect of myocarditis in children and the lack of data about its frequency. However, the committee decided the benefits from vaccination outweighed possible safety risks. This is based on a clinical trial involving 2,268 children, of which two-thirds were given the vaccine while the other third was given a placebo. During the clinical trial, 16 children who received the placebo developed COVID-19 compared with three children who were vaccined and became symptomatic with COVID-19, which is an efficacy of 91% at preventing symptomatic COVID-19.Some committee members expressed concern that the clinical trial was too small to properly quantify the risks of myocarditis, which is an inflammation of the heart. Children will receive two doses spaced three weeks apart, each containing 10 micrograms of mRNA, which is a third of the dosage given to adults. Here is the briefing document submitted to VRBPAC by Pfizer containing results of the clinical trials of Comirnaty in young children. The document specifically notes that myocarditis is associated with COVID-19 in children:Read more of this story at SoylentNews.